A 67-year-old man with intractable hypoglycaemia due to a malignant pancreatic insulinoma with multiple hepatic metastases is reported. Continuous intravenous infusion of dextrose was necessary to prevent life-threatening hypoglycaemia; high-dose parenteral octreotide was ineffective and oral diazoxide was associated with intolerable gastrointestinal si de\x=req-\ effects. Preoperative imaging failed to identify the primary tumour with certainty. At laparotomy, the tumour was located in the pancreas and excised. Intraoperative cryotherapy was administered to hepatic metastases inducing localised ice-ball formation and subsequent necrosis of the lesions. These interventions led to prompt resolution of the hypoglycaemia with normalisation of plasma concentrations of islet B-cell products. In an effort to consolidate the beneficial effects of surgery, chemotherapy was instituted post \ x=req-\ operatively using the islet B-cell toxin streptozotocin. In an innovative therapeutic approach, the drug was infused via the hepatic artery for 5 consecutive days at a reduced dose calculated to induce an insulitis in the residual hepatic metastases analogous to that described in murine models of diabetes. The chemotherapy was well tolerated although the course of treatment was curtailed by problems with catheter placement. Nonetheless, the patient has, to date, remained well and free from hypoglycaemia during more than 3 years of follow-up. These therapeutic strategies appear to merit further evaluation.
Introduction
Metastatic malignant insulinoma is an uncommon tumour accounting for approximately 10% of all cases of insulinomas. The prognosis for patients with advanced disease is generally poor with a reported median survival rate of only 26 months following chemotherapy (Moertel et al. 1980) . Nonetheless, individual patients have been reported with untreated metastatic disease who have survived for years or even decades.
Surgical ablation is regarded as the treatment of choice for malignant B-cell tumours. Removal of the primary lesion and resection of as many secondary deposits as possible may add years of useful life. Hepatic arterial embolisation has also been used with therapeutic success. As an adjunct to surgery, or in patients in whom surgery is considered contraindicated or inappropriate, medical therapy with diazoxide and chlorothiazide can be effective for prolonged periods (Marks & Rose 1981) . More recently, the long-acting somatostatin analogue octreotide has been used, either alone or in combin¬ ation with other agents (Stehouwer et (Moertel etal. 1980 (Fig. 3) . Fasting venous plasma glucose concentration at this review was 6.6 mmol/l with a normal plasma immunoreactive insulin concentration of 36 pmol/1 and an appropriate (Like & Rossini 1976 ). This slower-onset diabetes is associated with a marked lymphocytic insulitis suggesting a cell-mediated immune response. We hypothesised that a reduced dose of steptozotocin, administered by regional perfusion, might destroy the residual functioning hepatic metastases in our patient. Recognising the pitfalls of extrapolating between species we cannot be certain whether we succeeded in inducing an insulitis within the métastases; biopsy of the lesions was considered to be unjustified. However, in view of the generally poor prognosis of patients with malignant insulinomas, further evaluation of these therapeutic strategies appears to be warranted.
